04/06/2026
Historic Collaboration Between AMA and WHO Supports Africa’s Health Security Goals.
Addis Ababa, 4/2026 (ABN)
In a significant step toward strengthening public health systems across the continent, the African Medicines Agency and the World Health Organization have signed a new Framework Agreement for Collaboration on the margins of the Seventy-ninth World Health Assembly.
The landmark agreement underscores a shared commitment to enhancing Africa’s health security through stronger regulatory systems, improved access to quality medical products, and greater cooperation among health institutions across the continent.
The collaboration will focus on advancing regulatory harmonization among African countries, enabling more efficient and coordinated oversight of medicines, vaccines, and other healthcare products. By aligning regulatory standards and practices, the partnership aims to facilitate faster access to safe, effective, and quality-assured medical products for millions of people across Africa.
A key component of the agreement is strengthening surveillance and response mechanisms against substandard and falsified medical products, which continue to pose significant risks to public health and patient safety. Through enhanced cooperation and information sharing, AMA and WHO will support national authorities in protecting communities from unsafe and ineffective medical products.
The Framework Agreement also prioritizes workforce and institutional capacity building, recognizing the critical role of skilled professionals and strong regulatory institutions in ensuring effective healthcare governance. Joint initiatives will focus on technical training, knowledge exchange, and strengthening the capabilities of national regulatory agencies throughout Africa.
In addition, the partnership supports Africa’s growing ambition to expand local pharmaceutical and vaccine manufacturing. By fostering a more robust regulatory environment, the agreement is expected to encourage investment, innovation, and sustainable growth within the continent’s healthcare and life sciences sectors.
Efforts to accelerate approval pathways for medicines and vaccines will also form a central part of the collaboration. Streamlined regulatory processes are expected to improve the availability of life-saving health products while maintaining the highest standards of safety, quality, and efficacy.
The agreement represents a major milestone in Africa’s journey toward building a stronger, more resilient, and integrated regulatory ecosystem capable of responding effectively to emerging health challenges and future public health emergencies.